Scientific article

One Hundred Years of Congenital Fibrinogen Disorders

Published inSeminars in thrombosis and hemostasis, vol. 48, no. 8, p. 880-888
Publication date2022-09-02
First online date2022-09-02

Congenital fibrinogen disorders encompass a broad range of fibrinogen defects characterized by a wide molecular and clinical spectrum. From the first clinical description of afibrinogenemia in 1920, many major achievements have contributed to a better understanding of these complex disorders. The finding of causative mutations in all three fibrinogen genes has contributed to reveal the molecular mechanisms involved in biosynthesis of the fibrinogen molecule and to clarify the basic processes of fibrin polymerization and fibrinolysis. The compilation of abundant cases with detailed genetic, biological, and clinical features has enabled the classification of congenital fibrinogen disorders into several types and subtypes. Thus, the recent classification of congenital fibrinogen disorder is based not only on the clottable and antigenic fibrinogen levels but also on the patient's clinical phenotype and genotype. Fibrinogen supplementation is the cornerstone of bleeding management in fibrinogen disorders. Since the discovery of blood fractionation, the method of production of fibrinogen concentrate has been progressively modified to significantly improve purity and safety. Nevertheless, the availability of such products is still limited to a few countries and the optimal threshold of fibrinogen to target is still not established. In this review, we describe the major advances that have characterized 100 years of congenital fibrinogen disorders, focusing on afibrinogenemia and dysfibrinogenemia.

  • Afibrinogenemia
  • Dysfibrinogenemia
  • Fibrinogen
  • Fibrinogen / genetics
  • Genotype
  • Hemorrhage / genetics
  • Humans
  • Phenotype
  • Afibrinogenemia / genetics
  • Afibrinogenemia / therapy
  • Hemostatics
Citation (ISO format)
CASINI, Alessandro, DE MOERLOOSE, Philippe, NEERMAN ARBEZ, Marguerite. One Hundred Years of Congenital Fibrinogen Disorders. In: Seminars in thrombosis and hemostasis, 2022, vol. 48, n° 8, p. 880–888. doi: 10.1055/s-0042-1756187
Main files (1)
Article (Published version)
ISSN of the journal0094-6176

Technical informations

Creation09/06/2022 6:15:00 AM
First validation09/06/2022 6:15:00 AM
Update time03/16/2023 10:30:15 AM
Status update03/16/2023 10:30:14 AM
Last indexation08/31/2023 10:29:22 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack